Whalesbook
Camlin Fine Sciences Ltd (CFSL) shares climbed 5.74% on Friday following a strong endorsement from brokerage InCred Equities. The firm reiterated its 'Add' rating and set a target price of ₹480, betting on structurally tight vanillin markets in the U.S. and Europe to drive significant growth.
Vanillin Market Dynamics
InCred Equities highlighted that CFSL is strategically positioned to benefit from a global vanillin supply crunch. Prices in the U.S. are projected to exceed $32 per kilogram and in Europe €19 per kilogram by the second half of fiscal year 2027. Current spot prices in the U.S. are already around $20-22/kg.
CFSL's vanillin plant, which faced initial start-up issues including color inconsistency and chlorine contamination, is now operational. The brokerage pointed to limited local capacity, partial restarts of mothballed plants by competitors like Solvay, and punitive anti-dumping duties on Chinese imports as factors creating substantial supply gaps. These conditions are expected to structurally benefit non-Chinese suppliers such as CFSL.
Blend Portfolio and Acquisitions
The brokerage also emphasized CFSL's robust blend portfolio, comprising Xtendra (synthetic antioxidants), Nasure (natural antioxidants), and Ezential (high-value functional blends). These offerings are seen as creating significant entry barriers and unlocking revenue potential due to increasing formulation complexity and application specificity. The Ezential range, for instance, includes products like Ezential 4001, a paneer coagulant expected to generate approximately ₹65 crore annually in India alone.
The strategic acquisition of Vinpai further bolsters CFSL's position. This move transforms the company into a global platform for clean-label and natural solutions, providing access to around 3,000 products across diverse categories. Vinpai's Vin'Curd product offers a 30% yield improvement in the organized cheese market, potentially tapping into an addressable market of ₹430 crore, pending trials and regulatory approvals.